Top

Published in:

01-06-2014 | Review Article

Chemotherapy and Targeted Therapy for Gall Bladder Cancer

Authors: Bhawna Sirohi, Ashish Singh, P. Jagannath, Shailesh V. Shrikhande

Published in: Indian Journal of Surgical Oncology | Issue 2/2014

Abstract

Gall bladder cancer is a common cancer in the Ganges belt of North-eastern India. In view of incidental diagnosis of gall bladder cancer by physicians and surgeons, the treatment is not optimised. Most patients present in advanced stages and surgery remains the only option to cure. This review highlights the current evidence in advances in systemic therapy of gall bladder cancer.

Mahantshetty UM, Palled SR, Engineer R, Homkar G, Shrivastava SK, Shukla PJ (2006) Adjuvant radiation therapy in gall bladder cancers: 10 years experience at Tata memorial hospital. J Cancer Res Ther 2(2):52–56PubMedCrossRef

Jarnagin WR, Ruo L, Little SA, Klimstra D, D’Angelica M, DeMatteo RP et al (2003) Patterns of initial disease recurrence after resection of gallbladder carcinoma and hilar cholangiocarcinoma: implications for adjuvant therapeutic strategies. Cancer 98(8):1689–1700PubMedCrossRef

Murakami Y, Uemura K, Sudo T, Hayashidani Y, Hashimoto Y, Nakamura H et al (2009) Adjuvant gemcitabine plus S-1 chemotherapy improves survival after aggressive surgical resection for advanced biliary carcinoma. Ann Surg 250(6):950–956PubMedCrossRef

Morrow CE, Sutherland DE, Florack G, Eisenberg MM, Grage TB (1983) Primary gallbladder carcinoma: significance of subserosal lesions and results of aggressive surgical treatment and adjuvant chemotherapy. Surgery 94(4):709–714PubMed

Oswalt CE, Cruz AB Jr (1977) Effectiveness of chemotherapy in addition to surgery in treating carcinoma of the gallbladder. Rev Surg 34(6):436–438PubMed

Takada T, Amano H, Yasuda H, Nimura Y, Matsushiro T, Kato H et al (2002) Is postoperative adjuvant chemotherapy useful for gallbladder carcinoma? A phase III multicenter prospective randomized controlled trial in patients with resected pancreaticobiliary carcinoma. Cancer 95(8):1685–1695PubMedCrossRef

Duffy A, Capanu M, Abou-Alfa GK, Huitzil D, Jarnagin W, Fong Y et al (2008) Gallbladder cancer (GBC): 10-year experience at memorial sloan-kettering cancer centre (MSKCC). J Surg Oncol 98(7):485–489PubMedCrossRef

Valle J, Wasan H, Palmer DH, Cunningham D, Anthoney A, Maraveyas A et al (2010) Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer. N Engl J Med 362(14):1273–1281PubMedCrossRef

Nakeeb A, Tran KQ, Black MJ, Erickson BA, Ritch PS, Quebbeman EJ (2002) Improved survival in resected biliary malignancies. Surgery 132(4):555–563, discission 563–564PubMedCrossRef

10.

Mojica P, Smith D, Ellenhorn J (2007) Adjuvant radiation therapy is associated with improved survival for gallbladder carcinoma with regional metastatic disease. J Surg Oncol 96(1):8–13PubMedCrossRef

11.

Kraybill WG, Lee H, Picus J, Ramachandran G, Lopez MJ, Kucik N et al (1994) Multidisciplinary treatment of biliary tract cancers. J Surg Oncol 55(4):239–245PubMedCrossRef

12.

Gold DG, Miller RC, Haddock MG, Gunderson LL, Quevedo F, Donohue JH et al (2009) Adjuvant therapy for gallbladder carcinoma: the Mayo clinic experience. Int J Radiat Oncol Biol Phys 75(1):150–155PubMedCrossRef

13.

Todoroki T, Kawamoto T, Takahashi H, Takada Y, Koike N, Otsuka M et al (1999) Treatment of gallbladder cancer by radical resection. Br J Surg 86(5):622–627PubMedCrossRef

14.

Mahe M, Stampfli C, Romestaing P, Salerno N, Gerard JP (1994) Primary carcinoma of the gall-bladder: potential for external radiation therapy. Radiother Oncol J Eur Soc Ther Radiol Oncol 33(3):204–208CrossRef

15.

Mehta A, Bahadur AK, Aranya RC, Jain AK (1996) Role of radiation therapy in carcinoma of the gall bladder–a preliminary indian experience. Trop Gastroenterol Off J Dig Dis Found 17(1):22–25

16.

Nadler LH, McSherry CK (1992) Carcinoma of the gallbladder: review of the literature and report on 56 cases at the Beth Israel medical center. Mt Sinai J Med N Y 59(1):47–52

17.

Kresl JJ, Schild SE, Henning GT, Gunderson LL, Donohue J, Pitot H et al (2002) Adjuvant external beam radiation therapy with concurrent chemotherapy in the management of gallbladder carcinoma. Int J Radiat Oncol Biol Phys 52(1):167–175PubMedCrossRef

18.

Bosset JF, Mantion G, Gillet M, Pelissier E, Boulenger M, Maingon P (1989) Primary carcinoma of the gallbladder. Adjuvant postoperative external irradiation. Cancer 64(9):1843–1847PubMedCrossRef

19.

Todoroki T, Kawamoto T, Otsuka M, Koike N, Yoshida S, Takada Y et al (1999) Benefits of combining radiotherapy with aggressive resection for stage IV gallbladder cancer. Hepatogastroenterology 46(27):1585–1591PubMed

20.

Houry S, Barrier A, Huguier M (2001) Irradiation therapy for gallbladder carcinoma: recent advances. J Hepatobiliary Pancreat Surg 8(6):518–524PubMedCrossRef

21.

Czito BG, Hurwitz HI, Clough RW, Tyler DS, Morse MA, Clary BM et al (2005) Adjuvant external-beam radiotherapy with concurrent chemotherapy after resection of primary gallbladder carcinoma: a 23-year experience. Int J Radiat Oncol Biol Phys 62(4):1030–1034PubMedCrossRef

22.

Cho SY, Kim SH, Park S-J, Han S-S, Kim Y-K, Lee K-W et al (2010) Adjuvant chemoradiation therapy in gallbladder cancer. J Surg Oncol 102(1):87–93PubMedCrossRef

23.

Chao TC, Greager JA (1991) Primary carcinoma of the gallbladder. J Surg Oncol 46(4):215–221PubMedCrossRef

24.

Itoh H, Nishijima K, Kurosaka Y, Takegawa S, Kiriyama M, Dohba S et al (2005) Magnitude of combination therapy of radical resection and external beam radiotherapy for patients with carcinomas of the extrahepatic bile duct and gallbladder. Dig Dis Sci 50(12):2231–2242PubMedCrossRef

25.

Todoroki T, Iwasaki Y, Orii K, Otsuka M, Ohara K, Kawamoto T et al (1991) Resection combined with intraoperative radiation therapy (IORT) for stage IV (TNM) gallbladder carcinoma. World J Surg 15(3):357–366PubMedCrossRef

26.

Busse PM, Cady B, Bothe A Jr, Jenkins R, McDermott WV, Steele G Jr et al (1991) Intraoperative radiation therapy for carcinoma of the gallbladder. World J Surg 15(3):352–356PubMedCrossRef

27.

Lindell G, Holmin T, Ewers SB, Tranberg K-G, Stenram U, Ihse I (2003) Extended operation with or without intraoperative (IORT) and external (EBRT) radiotherapy for gallbladder carcinoma. Hepatogastroenterology 50(50):310–314PubMed

28.

Horgan AM, Amir E, Walter T, Knox JJ (2012) Adjuvant therapy in the treatment of biliary tract cancer: a systematic review and meta-analysis. J Clin Oncol 30(16):1934–1940PubMedCrossRef

29.

Wang SJ, Lemieux A, Kalpathy-Cramer J, Ord CB, Walker GV, Fuller CD et al (2011) Nomogram for predicting the benefit of adjuvant chemoradiotherapy for resected gallbladder cancer. J Clin Oncol Off J Am Soc Clin Oncol 29(35):4627–4632CrossRef

30.

Sirohi B, Singh A, Seth V. Neoadjuvant therapy in Indian patients with locally advanced gall bladder cancer: Tata Memorial Centre (TMC) experience. J Clin Oncol 32 2014 Suppl 3 Abstr 379 [Internet]. [cited 2014 Jan 18]; Available from: http://gicasym.org/content/122842-143

31.

De Aretxabala X, Roa I, Berrios M, Hepp J, Gallardo J, Cordova A et al (2006) Chemoradiotherapy in gallbladder cancer. J Surg Oncol 93(8):699–704PubMedCrossRef

32.

De Aretxabala X, Losada H, Mora J, Roa I, Burgos L, Yáñez E (2004) [Neoadjuvant chemoradiotherapy in gallbladder cancer]. Rev Médica Chile 132(1):51–57

33.

Engineer R, Wadasadawala T, Mehta S, Mahantshetty U, Purandare N, Rangarajan V et al (2011) Chemoradiation for unresectable gall bladder cancer: time to review historic nihilism? J Gastrointest Cancer 42(4):222–227PubMedCrossRef

34.

Kumaran V, Gulati S, Paul B, Pande K, Sahni P, Chattopadhyay K (2002) The role of dual-phase helical CT in assessing resectability of carcinoma of the gallbladder. Eur Radiol 12(8):1993–1999PubMedCrossRef

35.

Saluja SS, Gulati M, Garg PK, Pal H, Pal S, Sahni P (2008) Endoscopic or percutaneous biliary drainage for gallbladder cancer: a randomized trial and quality of life assessment. Clin Gastroenterol Hepatol Off Clin Pract J Am Gastroenterol Assoc 6(8):944–950

36.

Sharma A, Dwary AD, Mohanti BK, Deo SV, Pal S, Sreenivas V et al (2010) Best supportive care compared with chemotherapy for unresectable gall bladder cancer: a randomized controlled study. J Clin Oncol Off J Am Soc Clin Oncol 28(30):4581–4586CrossRef

37.

Patt YZ, Hassan MM, Aguayo A, Nooka AK, Lozano RD, Curley SA et al (2004) Oral capecitabine for the treatment of hepatocellular carcinoma, cholangiocarcinoma, and gallbladder carcinoma. Cancer 101(3):578–586PubMedCrossRef

38.

Ducreux M, Rougier P, Fandi A, Clavero-Fabri MC, Villing AL, Fassone F et al (1998) Effective treatment of advanced biliary tract carcinoma using 5-fluorouracil continuous infusion with cisplatin. Ann Oncol Off J Eur Soc Med Oncol ESMO 9(6):653–656CrossRef

39.

Rao S, Cunningham D, Hawkins RE, Hill ME, Smith D, Daniel F et al (2005) Phase III study of 5FU, etoposide and leucovorin (FELV) compared to epirubicin, cisplatin and 5FU (ECF) in previously untreated patients with advanced biliary cancer. Br J Cancer 92(9):1650–1654PubMedCentralPubMedCrossRef

40.

Nehls O, Oettle H, Hartmann JT, Hofheinz R-D, Hass HG, Horger MS et al (2008) Capecitabine plus oxaliplatin as first-line treatment in patients with advanced biliary system adenocarcinoma: a prospective multicentre phase II trial. Br J Cancer 98(2):309–315PubMedCentralPubMedCrossRef

41.

Riechelmann RP, Townsley CA, Chin SN, Pond GR, Knox JJ (2007) Expanded phase II trial of gemcitabine and capecitabine for advanced biliary cancer. Cancer 110(6):1307–1312PubMedCrossRef

42.

Cho J-Y, Nam J-S, Park M-S, Yu J-S, Paik Y-H, Lee S-J et al (2005) A Phase II study of capecitabine combined with gemcitabine in patients with advanced gallbladder carcinoma. Yonsei Med J 46(4):526–531PubMedCentralPubMedCrossRef

43.

Valle JW, Furuse J, Jitlal M, Beare S, Mizuno N, Wasan H, et al. Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials. Ann Oncol Off J Eur Soc Med Oncol ESMO. 2013 Dec 18;

44.

André T, Tournigand C, Rosmorduc O, Provent S, Maindrault-Goebel F, Avenin D et al (2004) Gemcitabine combined with oxaliplatin (GEMOX) in advanced biliary tract adenocarcinoma: a GERCOR study. Ann Oncol Off J Eur Soc Med Oncol ESMO 15(9):1339–1343CrossRef

45.

Philip PA, Mahoney MR, Allmer C, Thomas J, Pitot HC, Kim G et al (2006) Phase II study of erlotinib in patients with advanced biliary cancer. J Clin Oncol Off J Am Soc Clin Oncol 24(19):3069–3074CrossRef

46.

Lubner SJ, Mahoney MR, Kolesar JL, Loconte NK, Kim GP, Pitot HC et al (2010) Report of a multicenter phase II trial testing a combination of biweekly bevacizumab and daily erlotinib in patients with unresectable biliary cancer: a phase II Consortium study. J Clin Oncol Off J Am Soc Clin Oncol 28(21):3491–3497CrossRef

47.

NCT00363584. Capecitabine or Observation After Surgery in Treating Patients With Biliary Tract Cancer [Internet]. Available from: http://clinicaltrials.gov/ct2/show/NCT00363584?term=BILCAP+trial&rank=1

48.

Ben-David MA, Griffith KA, Abu-Isa E, Lawrence TS, Knol J, Zalupski M et al (2006) External-beam radiotherapy for localized extrahepatic cholangiocarcinoma. Int J Radiat Oncol Biol Phys 66(3):772–779PubMedCrossRef

49.

González ME, Giannini OH, González P, Saldaña B (2011) Adjuvant radio-chemotherapy after extended or simple cholecystectomy in gallbladder cancer. Clin Transl Oncol Off Publ Fed Span Oncol Soc Natl Cancer Inst Mex 13(7):480–484

50.

De Aretxabala X, Roa I, Burgos L, Cartes R, Silva J, Yañez E et al (1999) Preoperative chemoradiotherapy in the treatment of gallbladder cancer. Am Surg 65(3):241–246PubMed

51.

Okusaka T, Nakachi K, Fukutomi A, Mizuno N, Ohkawa S, Funakoshi A et al (2010) Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan. Br J Cancer 103(4):469–474PubMedCentralPubMedCrossRef

52.

Knox JJ, Hedley D, Oza A, Feld R, Siu LL, Chen E et al (2005) Combining gemcitabine and capecitabine in patients with advanced biliary cancer: a phase II trial. J Clin Oncol Off J Am Soc Clin Oncol 23(10):2332–2338CrossRef

53.

Cho JY, Paik YH, Chang YS, Lee SJ, Lee D-K, Song SY et al (2005) Capecitabine combined with gemcitabine (CapGem) as first-line treatment in patients with advanced/metastatic biliary tract carcinoma. Cancer 104(12):2753–2758PubMedCrossRef

54.

Iyer RV, Gibbs J, Kuvshinoff B, Fakih M, Kepner J, Soehnlein N et al (2007) A phase II study of gemcitabine and capecitabine in advanced cholangiocarcinoma and carcinoma of the gallbladder: a single-institution prospective study. Ann Surg Oncol 14(11):3202–3209PubMedCrossRef

55.

Thongprasert S, Napapan S, Charoentum C, Moonprakan S (2005) Phase II study of gemcitabine and cisplatin as first-line chemotherapy in inoperable biliary tract carcinoma. Ann Oncol Off J Eur Soc Med Oncol ESMO 16(2):279–281CrossRef

56.

Meyerhardt JA, Zhu AX, Stuart K, Ryan DP, Blaszkowsky L, Lehman N et al (2008) Phase-II study of gemcitabine and cisplatin in patients with metastatic biliary and gallbladder cancer. Dig Dis Sci 53(2):564–570PubMedCrossRef

57.

Kim ST, Park JO, Lee J, Lee KT, Lee JK, Choi S-H et al (2006) A Phase II study of gemcitabine and cisplatin in advanced biliary tract cancer. Cancer 106(6):1339–1346PubMedCrossRef

58.

Harder J, Riecken B, Kummer O, Lohrmann C, Otto F, Usadel H et al (2006) Outpatient chemotherapy with gemcitabine and oxaliplatin in patients with biliary tract cancer. Br J Cancer 95(7):848–852PubMedCentralPubMedCrossRef

59.

Verderame F, Russo A, Di Leo R, Badalamenti G, Santangelo D, Cicero G, et al. Gemcitabine and oxaliplatin combination chemotherapy in advanced biliary tract cancers. Ann Oncol Off J Eur Soc Med Oncol ESMO. 2006 Jun;17 Suppl 7:vii68–72.

60.

Doval DC, Sekhon JS, Gupta SK, Fuloria J, Shukla VK, Gupta S et al (2004) A phase II study of gemcitabine and cisplatin in chemotherapy-naive, unresectable gall bladder cancer. Br J Cancer 90(8):1516–1520PubMedCentralPubMedCrossRef

61.

Gallardo JO, Rubio B, Fodor M, Orlandi L, Yáñez M, Gamargo C et al (2001) A phase II study of gemcitabine in gallbladder carcinoma. Ann Oncol Off J Eur Soc Med Oncol ESMO 12(10):1403–1406CrossRef

62.

Gruenberger B, Schueller J, Heubrandtner U, Wrba F, Tamandl D, Kaczirek K et al (2010) Cetuximab, gemcitabine, and oxaliplatin in patients with unresectable advanced or metastatic biliary tract cancer: a phase 2 study. Lancet Oncol 11(12):1142–1148PubMedCrossRef

63.

Lee J, Park SH, Chang H-M, Kim JS, Choi HJ, Lee MA et al (2012) Gemcitabine and oxaliplatin with or without erlotinib in advanced biliary-tract cancer: a multicentre, open-label, randomised, phase 3 study. Lancet Oncol 13(2):181–188PubMedCrossRef

64.

Jensen LH, Lindebjerg J, Ploen J, Hansen TF, Jakobsen A (2012) Phase II marker-driven trial of panitumumab and chemotherapy in KRAS wild-type biliary tract cancer. Ann Oncol Off J Eur Soc Med Oncol ESMO 23(9):2341–2346CrossRef

65.

Sohal DPS, Mykulowycz K, Uehara T, Teitelbaum UR, Damjanov N, Giantonio BJ et al (2013) A phase II trial of gemcitabine, irinotecan and panitumumab in advanced cholangiocarcinoma. Ann Oncol Off J Eur Soc Med Oncol ESMO 24(12):3061–3065CrossRef

66.

Zhu AX, Meyerhardt JA, Blaszkowsky LS, Kambadakone AR, Muzikansky A, Zheng H et al (2010) Efficacy and safety of gemcitabine, oxaliplatin, and bevacizumab in advanced biliary-tract cancers and correlation of changes in 18-fluorodeoxyglucose PET with clinical outcome: a phase 2 study. Lancet Oncol 11(1):48–54PubMedCrossRef

67.

Bekaii-Saab T, Phelps MA, Li X, Saji M, Goff L, Kauh JSW et al (2011) Multi-institutional phase II study of selumetinib in patients with metastatic biliary cancers. J Clin Oncol Off J Am Soc Clin Oncol 29(17):2357–2363CrossRef

Title: Chemotherapy and Targeted Therapy for Gall Bladder Cancer
Authors: Bhawna Sirohi
Ashish Singh
P. Jagannath
Shailesh V. Shrikhande
Publication date: 01-06-2014
Publisher: Springer India
Published in: Indian Journal of Surgical Oncology / Issue 2/2014
Print ISSN: 0975-7651
Electronic ISSN: 0976-6952
DOI: https://doi.org/10.1007/s13193-014-0317-4

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Chemotherapy and Targeted Therapy for Gall Bladder Cancer

Abstract

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Abstract

Please log in to get access to this content

Other articles of this Issue 2/2014

The Aesthetic and Oncological Challenges in the Management of an Atypical Nodular Hidradenoma of the Pinna

The Risk and Pattern of Pelvic and Para Aortic Lymph Nodal Metastasis in Patients with Intermediate and High Risk Endometrial Cancer

Intussusception of a Small Bowel Large B-Cell Lymphoma

Right Hepatectomy in Icteric Type Hepatocellular Carcinoma—Report of a Case and Literature Review

Chondroradionecrosis of Larynx a Delayed Complication of Radiotherapy: Management and Review of Literature

Editorial